EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, AMLX: Amylyx Pharmaceuticals Inc

23 Jan 26 15:59
LAST:

15.76

CHANGE:
 0.47		OPEN:
16.09		HIGH:
16.53		ASK:
0.00		VOLUME:
818.2K
CHG(%):
2.90		PREV:
16.23		LOW:
15.63		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Jan 2616.1616.5315.6315.761.38M
22 Jan 2617.0017.4916.1416.232.15M
21 Jan 2616.3417.2016.1516.923.6M
20 Jan 2613.9916.8013.9016.554.42M
16 Jan 2613.5614.6513.4514.301.71M
15 Jan 2614.1314.2613.2213.522.36M
14 Jan 2612.6114.1212.5914.071.8M
13 Jan 2612.3812.6212.0812.601.23M
12 Jan 2612.2212.4712.1812.391.04M
09 Jan 2611.8812.5011.7712.211.21M

PROFILE

Name:Amylyx Pharmaceuticals Inc
About:Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:43 Thorndike Street, Cambridge, MA, United States, 02141
Website:https://amylyx.com
CUSIP:032108508
CIK:0001658551
ISIN:US0321085088
FIGI:BBG00DP10YT5
LEI:549300N7RNU56EKK7U80

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:2.54 
Forward P/E:-9.60 
PEG Ratio:-0.04 
Price to Sales:-5,967.38 
Price to Book:3.96 
Profit Margin:-0.43 
Operating Margin:791.06 
Return on Assets:-0.47 
Return on Equity:-0.87 
EPS Ratio:-1.79 
Revenue:-249,000 
Shares:109.82M 
Market Cap:1.731B 

TECHNICAL INDICATORS

MA5:15.951.2%
MA10:14.469.0%
MA20:13.1819.6%
MA50:13.3318.2%
MA100:13.2918.6%
MA200:9.8160.7%
STO9:66.08
STO14:71.69
RSI14:76.59 
WPR14:-20.94
MTM14:4.37
ROC14:0.38 
ATR:1.02 
Week High:17.4911.0%
Week Low:13.4517.2%
Month High:17.4911.0%
Month Low:10.8360.7%
Year High:17.4911.0%
Year Low:2.60506.2%